Oxurion will make Bitcoin and Ethereum investments in 12 tranches, with each tranch of 2.5 million Euros in bonds, issued at a 10% discount. The program is designed to strengthen Oxurion’s treasury and support its broader strategy. Leuven-based pharmaceutical firm Oxurion NV (Euronext Brussels: OXUR) has recently entered into a subscription agreement with Atlas Capital [...]]]>Oxurion will make Bitcoin and Ethereum investments in 12 tranches, with each tranch of 2.5 million Euros in bonds, issued at a 10% discount. The program is designed to strengthen Oxurion’s treasury and support its broader strategy. Leuven-based pharmaceutical firm Oxurion NV (Euronext Brussels: OXUR) has recently entered into a subscription agreement with Atlas Capital [...]]]>

Belgian Pharma Oxurion to Invest in Bitcoin and Ethereum After Securing Major €30M Facility

  • Oxurion will make Bitcoin and Ethereum investments in 12 tranches, with each tranch of 2.5 million Euros in bonds, issued at a 10% discount.
  • The program is designed to strengthen Oxurion’s treasury and support its broader strategy.

Leuven-based pharmaceutical firm Oxurion NV (Euronext Brussels: OXUR) has recently entered into a subscription agreement with Atlas Capital Markets for a 30 million Euro financing program through the issuance of convertible bonds. The firm will deploy the funds for its long-term digital asset investment strategy, which is focused on Bitcoin and Ethereum, as per the July update. The financing is structured in 12 tranches of 2.5 million Euro each.

Oxurion Reveals Its Bitcoin and Ethereum Investment Strategy

Under the agreement, Atlas Capital Markets will subscribe to convertible bonds that can be exchanged for Oxurion’s ordinary shares. Each tranche is issued at 90% of its nominal 2.5 million Euro value and contains 100 bonds with a nominal value of 25,000 Euro each.

Across all 12 tranches, the program totals 1,200 individually registered bonds amounting to 30 million Euro. This is the first major Bitcoin treasury announcement following that of the Texas government last week, as per the CNF report.

Each tranche of convertible bonds will mature in 12 months, with the entire program capped at a 24-month deadline from the signing date. The bonds carry a 6% annual coupon plus the applicable Euribor rate. The conversion price will be determined separately for each tranche, calculated on the 15-day volume-weighted average price (VWAP) of Oxurion shares prior to issuance, with an added premium of 10% to ensure up-to-date valuations throughout the program.

A key condition of the structure is that at least 85% of the funds raised must be invested in Bitcoin and Ethereum, held in a dedicated account, while the remainder supports associated hedging. Ethereum is not the preferred choice for investment among European asset managers, but also for launching tokenized funds, as mentioned earlier.

These digital assets may be unlocked if the 15-day VWAP of Oxurion shares exceeds the tranche’s conversion price by 30%, allowing the release of up to 20% of the company’s average traded value over the preceding 15 sessions.

As part of the security package, Atlas Capital Markets will receive a first-ranking pledge over all bank accounts used in the financing program, including the digital asset account.

Financing Terms And Capital Allocation

The initial 2.5 million Euro tranche will be released once all conditions precedent are met, after deducting a 900,000 Euro commission specified in the agreement. Subsequent tranches will be disbursed later on, provided that 75% of the convertible bonds from the previous tranche have been converted into shares and all conditions precedent remain satisfied.

Oxurion’s digital asset investment strategy aims to strengthen the company’s financial position by gaining long-term exposure to major cryptocurrencies like Bitcoin and Ether. The company said the approach is intended to secure and optimize available resources while supporting its broader ambition to emerge as a leading European player in clinical data and biotechnology.

]]>
Piyasa Fırsatı
Major Logosu
Major Fiyatı(MAJOR)
$0,10895
$0,10895$0,10895
-5,79%
USD
Major (MAJOR) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Exodus Partners with MoonPay to Launch Fully Reserved USD-Backed Stablecoin on M0 Infrastructure

Exodus Partners with MoonPay to Launch Fully Reserved USD-Backed Stablecoin on M0 Infrastructure

Exodus, known for its user-friendly self-custody wallet supporting multiple blockchains, will integrate the new stablecoin into its product suite, providing its user base with seamless access to the digital dollar. MoonPay, which has established itself as a leading fiat on-ramp and off-ramp service, brings its payment rails and regulatory relationships to the partnership. M0, a newer entrant focused specifically on stablecoin infrastructure, provides the underlying technology stack.
Paylaş
MEXC NEWS2025/12/17 12:35
Aave Founder Unveils 2026 Master Plan: V4 Upgrade, Institutional RWA Platform Horizon, and New Application

Aave Founder Unveils 2026 Master Plan: V4 Upgrade, Institutional RWA Platform Horizon, and New Application

Aave founder Stani Kulechov recently unveiled the decentralized lending protocol's 2026 strategic plan, revealing an ambitious development blueprint. This master plan centers on three core pillars: the next-generation Aave V4 protocol upgrade, Horizon—a real-world asset (RWA) platform built specifically for institutional investors—and a new Aave application designed to lower barriers for users. In presenting this roadmap, Kulechov demonstrated unwavering confidence in Aave's future, concluding with a succinct and powerful declaration: "Aave will win."
Paylaş
MEXC NEWS2025/12/17 12:25
OpenAI in Talks to Raise $10B+ from Amazon, Plans to Adopt Amazon's AI Chips

OpenAI in Talks to Raise $10B+ from Amazon, Plans to Adopt Amazon's AI Chips

According to The Information, OpenAI is in discussions with Amazon regarding an investment exceeding $10 billion and plans to adopt Amazon's artificial intelligence chips. If confirmed, this would mark a momentous strategic alliance between two heavyweight players in the AI space. For OpenAI, this potential funding would provide ample capital for its continuously expanding AI infrastructure development. The computational costs required to train and run large language models are extraordinarily high, and rapid user growth has further intensified demand for computing resources. Additional capital injection would help OpenAI maintain its technological edge in the ongoing AI arms race.
Paylaş
MEXC NEWS2025/12/17 12:28